Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer.

Masato KarayamaJ MasudaK MoriH YasuiH HozumiY SuzukiK FuruhashiT FujisawaN EnomotoY NakamuraN InuiT SudaM MaekawaH SugimuraA Takada

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)

University Hospital Medical Information Network Clinical Trial Registry 000026140.

Keyphrases

clinical trial
healthcare
ms ms
open label
phase ii
health information
study protocol
double blind
randomized controlled trial
phase iii